Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism

NCT04727437 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT04727437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04727437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism
Lead sponsor
University of Birmingham
Phase
Phase 3
Overall status
Unknown status
Start date
April 8, 2021
Completion date
May 31, 2024
Enrollment
1,466 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

subsegmental pulmonary embolism nos